Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6405166 | 0.87 | MAPT (0.71) | ALDH1A1MAPTKMT2APOLBGAA | |
| SCHEMBL18559221 | 0.86 | ALDH1A1 (0.83) | HTTALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL15983398 | 0.85 | ALDH1A1 (0.80) | HTTALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL15983410 | 0.79 | TSHR (0.66) | HTTALDH1A1MAPK1MAPTCYP3A4 | |
| SCHEMBL4209713 | 0.78 | ALDH1A1 (0.79) | ALDH1A1MAPK1MAPTLMNAMEN1 | |
| SCHEMBL4212044 | 0.78 | MAPT (0.77) | HTTALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL4203301 | 0.77 | CYP1A2 (0.77) | HTTALDH1A1MAPK1MAPTCYP3A4 | |
| SCHEMBL20682641 | 0.77 | LMNA (0.65) | HTTALDH1A1MAPK1MAPTCYP3A4 | |
| SCHEMBL19566994 | 0.77 | TSHR (0.64) | HTTALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL18559160 | 0.77 | ALDH1A1 (1.00) | ALDH1A1MAPK1MAPTLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | HTT 2113/4885ALDH1A1 720/4885MAPK1 4613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.